Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q4 FY19 results · Jan–Mar 2019
Caplin Point Laboratories reported revenue from operations of ₹187.34 crore and net profit of ₹49.86 crore for Q4 FY19 (Jan–Mar 2019), on a consolidated basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 187.34 | — | — | — | — |
| Other income | 2.67 | — | — | — | — |
| Total income | 190.01 | — | — | — | — |
| Profit before tax | 60.69 | — | — | — | — |
| Net profit for the period | 49.86 | — | — | — | — |
| Attributable to shareholders of the company | 49.81 | — | — | — | — |
| EPS, basic (₹) | 6.58 | — | — | — | — |
| Net margin (%) | 26.6 | — | — |
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 140.74 | — | — | 139.76 | +0.7% |
| Other income | 3.31 | — | — | 7.37 | −55.0% |
| Total income | 144.06 | — | — | 147.13 | −2.1% |
| Profit before tax | 55.33 | — | — | 50.86 | +8.8% |
| Net profit for the period | 40.32 | — | — | 36.86 | +9.4% |
| EPS, basic (₹) | 5.34 | — | — | 4.88 | +9.4% |
| Net margin (%) | 28.7 | — | 26.4 |
Consolidated
- Filed with BSE
- 27 May 2019, 16:34 IST
- Board meeting
- 22 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2019, 16:34 IST
- Board meeting
- 22 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE